Second, cutaneous B-cell infiltrates with a CD5- and CD23-positive phenotype should prompt evaluation for CLL/SLL with appropriate staging, as these findings favor secondary involvement rather than primary cutaneous lymphomas. Here, FCER2 is linked to B-cell chronic lymphocytic leukemia.